Advent Announces Corporate Name Change to Advaxia

Featured Image for Advaxia

Featured Image for Advaxia

POMEZIA, Italy, Sept. 27, 2022 (GLOBE NEWSWIRE) — Advent announced today that it is changing its corporate name to Advaxia. The new name reflects the company’s evolution, strategic growth and expanding commitment to global human health, including its expertise in vaccine development and manufacturing.

The company also announced the launch of its new website www.advaxia.com. The new site showcases Advaxia’s transformed corporate branding and provides detailed content on the company’s integrated contract development, manufacturing, and testing capabilities for viral vaccines.

Dr Piero Di Lorenzo, President and CEO of Advaxia and IRBM, said:

“Our new identity and corporate name, Advaxia, better represents our strategic focus. We are committed to advancing science through the development and manufacturing of high-quality vaccines and therapeutics for infectious diseases and gene therapy, and this commitment is accelerating the growth of our organisation.”   

“Advaxia has been recognised as a leader in the production of adenovirus vaccines for over a decade and has successfully developed and manufactured clinical trial materials for numerous clients, including COVID-19 vaccine candidates. To support further growth, by the end of 2022, the company plans to complete the expansion of its manufacturing capabilities, including a high-speed fill & finish line.” 

About Advaxia 

Advaxia, a wholly owned subsidiary of IRBM, is dedicated to the development and production of clinical lots of recombinant adenoviruses to support clinical trials for vaccine and gene therapy applications in compliance with EMA, FDA and MHRA regulations. The Advaxia team has built an outstanding track record in the production of clinical lots for many infectious diseases, including Ebola and HIV, and supported the global effort to expedite the delivery of a COVID-19 vaccine.

IRBM is an innovative contract research organisation working across all aspects of drug discovery and early development, supporting the pharmaceutical, biotech, non-profit and academic sectors to accelerate the development of novel medicines and vaccines. For more information, please visit www.irbm.com.
For further information, images and interview opportunities, please contact:

Patrick DePalma
VP, Global Business Development & Marketing
Tel: +39 (0)691093769
Email: media@advaxia.com

For the full press release, click here.

Contact Information:
Patrick DePalma
VP, Global Business Development & Marketing
media@advaxia.com
+390691093692

Related Images

Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment


The Globe and Mail Announces That LeddarTech Has Been Selected as One of Canada’s Top Growing Companies

QUEBEC CITY, Sept. 27, 2022 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce its recognition among Canada’s Top Growing Companies for 2022 by the Globe and Mail’s Report on Business, where LeddarTech ranked 280 out of 430 eligible companies.

The Canada’s Top Growing Companies list ranks Canadian companies on three-year revenue growth. LeddarTech thus continues to be recognized for its market-leading technology and business practices and, most recently, received two awards for its LeddarVision™ sensor fusion and perception software solution.

Canada’s Top Growing Companies is an editorial ranking launched in 2019. It aims to celebrate the boldest entrepreneurial achievement by identifying and bringing the accomplishments of innovative businesses in Canada to the forefront. In order to qualify for this voluntary program, companies had to complete an in-depth application process and fulfill requirements. In total, 430 companies earned a spot on this year’s ranking.

“LeddarTech is very honored to be named by the Globe and Mail’s Report on Business as one of Canada’s Top Growing Companies,” stated Charles Boulanger, CEO of LeddarTech. “LeddarTech began in Canada in 2007 with a commitment to developing technology that improves people’s quality of life, increases public safety and encourages greater global environmental sustainability. In 2022 we celebrate our 15th anniversary, and our commitments have not changed,” Mr. Boulanger continued. “On behalf of the management team, Board of Directors and our employees, I express our collective appreciation for this recognition. We remain motivated to continue our mission to become the most deployed sensor fusion and perception software solution that enables ADAS and AD applications.”

“Canada’s Top Growing Companies recognizes the tremendous ambition and innovation of entrepreneurs in Canada,” says Dawn Calleja, Editor of Report on Business magazine. “The next generation of Canadian businesses can draw inspiration from this ranking.”

“In an uncertain world, the success stories of the companies marked in this year’s Report on Business magazine’s list of Top Growing Companies are a beacon of optimism,” says Phillip Crawley, Publisher and CEO of The Globe and Mail. “The Globe and Mail congratulates them on their achievements.”

About The Globe and Mail

The Globe and Mail is Canada’s foremost news media company, leading the national discussion and causing policy change through brave and independent journalism since 1844. With award-winning coverage of business, politics and national affairs, The Globe and Mail newspaper reaches 5.9 million readers every week in print or digital formats, and Report on Business magazine reaches 2.3 million readers in print and digital every issue. The Globe and Mail’s investment in innovative data science means that as the world continues to change, so does The Globe. The Globe and Mail is owned by Woodbridge, the investment arm of the Thomson family.

About LeddarTech

Founded in 2007, LeddarTech is a comprehensive end-to-end environmental sensing company that enables customers to solve critical sensing, fusion and perception challenges across the entire value chain. LeddarTech provides cost-effective perception solutions scalable from Level 2 ADAS to Level 5 full autonomy with LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model from a variety of sensor types and configurations. LeddarTech also supports LiDAR manufacturers and Tier 1-2 automotive suppliers with key technology building blocks such as LeddarSteer™ digital beam steering and the LeddarEngine™, which comprises a highly integrated, scalable LiDAR SoC and software combination that enables the accelerated design of automotive-grade LiDAR solutions with optimized cost-to-performance ratios. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 140 patents granted or applied for, enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com

Investor relations contact: InvestorRelations@leddartech.com
https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

The Globe and Mail ประกาศว่า LeddarTech ได้รับเลือกให้เป็นหนึ่งในบริษัทที่เติบโตอันดับต้น ๆ ของแคนาดา

ควิเบกซิตี้, Sept. 27, 2022 (GLOBE NEWSWIRE) — LeddarTech® ผู้นำระดับโลกในการจัดหาเทคโนโลยีการตรวจจับ ADAS และ AD ที่ยืดหยุ่น แข็งแกร่ง และแม่นยำที่สุด มีความยินดีที่จะประกาศให้ทราบว่าบริษัทได้รับการยอมรับในกลุ่มบริษัทที่เติบโตสูงสุดของแคนาดาในปี 2022 โดย Globe and Mail’s Report on Business โดยที่ LeddarTech อยู่ในอันดับที่ 280 จาก 430 บริษัทที่เข้าเกณฑ์

รายชื่อ Canada’s Top Growing Companies ได้จัดอันดับบริษัทต่าง ๆ ในแคนาดาในด้านการเติบโตของรายได้สามปี LeddarTech ยังคงเป็นที่รู้จักในด้านเทคโนโลยีชั้นนำของตลาดและการดำเนินธุรกิจ และล่าสุด ก็ได้รับรางวัลสอง รางวัล ในด้านโซลูชันซอฟต์แวร์ฟิวชันเซ็นเซอร์และการรับรู้ LeddarVision™

Canada’s Top Growing Companies คือการจัดอันดับโดยบรรณาธิการที่เปิดตัวในปี 2019 การจัดอันดับนี้มีจุดมุ่งหมายเพื่อเฉลิมฉลองความสำเร็จของผู้ประกอบการที่กล้าหาญที่สุดโดยการระบุและนำความสำเร็จของธุรกิจนวัตกรรมในแคนาดาไปสู่ระดับแนวหน้า บริษัทต่าง ๆ จะต้องดำเนินการตามขั้นตอนการสมัครในเชิงลึกและปฏิบัติตามข้อกำหนดให้เสร็จสิ้นเพื่อให้มีคุณสมบัติสำหรับโปรแกรมอาสาสมัครนี้ โดยรวมแล้ว จะมีบริษัท 430 แห่งที่ได้รับตำแหน่งในการจัดอันดับในปีนี้

“ทาง LeddarTech รู้สึกเป็นเกียรติอย่างมากครับ ที่ทางบริษัทได้รับการเสนอชื่อจาก Globe and Mail’s Report on Business ให้เป็นหนึ่งในบริษัทที่เติบโตอันดับต้น ๆ ของแคนาดา” Charles Boulanger ซีอีโอของ LeddarTech กล่าว “LeddarTech เริ่มต้นในแคนาดาในปี 2007 ด้วยความมุ่งมั่นในการพัฒนาเทคโนโลยีที่ช่วยปรับปรุงคุณภาพชีวิตของผู้คน เพิ่มความปลอดภัยสาธารณะ และส่งเสริมความยั่งยืนด้านสิ่งแวดล้อมทั่วโลกมากขึ้น ในปี 2022 เราเฉลิมฉลองการครบรอบ 15 ปีของเรา และคำมั่นสัญญาของเราก็ไม่เปลี่ยนแปลง” คุณ Boulanger กล่าวต่อ “ในนามของทีมผู้บริหาร คณะกรรมการ และพนักงานของเรา ผมขอแสดงความขอบคุณแทนทุกคนสำหรับการยอมรับนี้ครับ เรายังคงมีแรงจูงใจที่จะสานต่อภารกิจของเราในการเป็นโซลูชันซอฟต์แวร์การรับรู้และฟิวชันเซ็นเซอร์ที่มีการปรับใช้ได้มากที่สุด ซึ่งช่วยให้สามารถใช้งานแอปพลิเคชัน ADAS และ AD ได้”

“บริษัทที่เติบโตอันดับต้น ๆ ของแคนาดาต่างก็ตระหนักถึงความทะเยอทะยานและนวัตกรรมอันยิ่งใหญ่ของผู้ประกอบการรายต่าง ๆ ในแคนาดา” Dawn Calleja บรรณาธิการนิตยสาร Report on Business กล่าว “ธุรกิจรุ่นต่อไป ๆ ของแคนาดาสามารถดึงแรงบันดาลใจจากการจัดอันดับนี้ออกมาได้”

Phillip Crawley ผู้จัดพิมพ์และซีอีโอของ The Globe and Mail กล่าวว่า “ในโลกที่ไม่แน่นอนนี้ เรื่องราวความสำเร็จของบริษัทต่าง ๆ ที่อยู่ในรายชื่อบริษัทที่เติบโตสูงสุดในรายงานประจำปีนี้ของนิตยสาร Business ถือเป็นสัญญาณของการมองการเติบโตในแง่ดี “The Globe and Mail ขอแสดงความยินดีกับความสำเร็จของบริษัทต่าง ๆ ด้วยครับ”

เกี่ยวกับ The Globe and Mail

The Globe and Mail เป็นบริษัทสื่อข่าวระดับแนวหน้าของแคนาดา เป็นผู้นำการอภิปรายระดับชาติและก่อให้เกิดการเปลี่ยนแปลงนโยบายผ่านการทำข่าวที่กล้าหาญและเป็นอิสระตั้งแต่ปี 1844 ด้วยการรายงานข่าวด้านธุรกิจ การเมือง และกิจการระดับชาติที่ได้รับรางวัล หนังสือพิมพ์ The Globe and Mail มีผู้อ่านถึง 5.9 ล้านคนทุกสัปดาห์ในรูปแบบสิ่งพิมพ์หรือดิจิทัล และนิตยสาร Report on Business มีผู้อ่านถึง 2.3 ล้านคนในรูปแบบสิ่งพิมพ์และดิจิทัลทุกฉบับ การลงทุนของ Globe and Mail ในด้านวิทยาศาสตร์ข้อมูลเชิงนวัตกรรมนั้นแสดงความหมายออกมาว่า ในขณะที่โลกยังคงเปลี่ยนแปลงไปเรื่อย ๆ นั้น The Globe ก็เปลี่ยนแปลงตามด้วยเช่นกัน The Globe and Mail เป็นเจ้าของโดย Woodbridge ซึ่งเป็นหน่วยงานด้านการลงทุนของตระกูล Thomson

เกี่ยวกับ LeddarTech

LeddarTech ก่อตั้งขึ้นในปี 2007 โดยเป็นบริษัทตรวจจับข้อมูลด้านสิ่งแวดล้อมแบบครบวงจรที่ครอบคลุม ซึ่งช่วยให้ลูกค้าสามารถแก้ปัญหาด้านการตรวจจับ การฟิวชัน และการรับรู้ที่สำคัญตลอดทั้งห่วงโซ่คุณค่า LeddarTech มอบโซลูชันการรับรู้ที่คุ้มค่าซึ่งปรับขนาดได้ตั้งแต่ ADAS ระดับ 2 ไปจนถึงระดับ 5 แบบอิสระเต็มรูปแบบด้วย LeddarVision™ ซึ่งเป็นฟิวชันเซ็นเซอร์ข้อมูลดิบและแพลตฟอร์มการรับรู้ที่สร้างแบบจำลองสภาพแวดล้อม 3 มิติที่ครอบคลุมจากเซ็นเซอร์และการกำหนดค่าหลากหลายประเภท LeddarTech ยังให้การสนับสนุนผู้ผลิต LiDAR รวมถึงซัพพลายเออร์ยานยนต์ระดับ 1-2 อีกด้วย ด้วยโครงสร้างเทคโนโลยีที่สำคัญต่าง ๆ เช่น ระบบบีมสเตียริ่งดิจิทัล LeddarSteer™ และ LeddarEngine™ ซึ่งประกอบด้วย LiDAR SoC แบบครบวงจรและปรับขนาดได้สูงและชุดซอฟต์แวร์ผสมที่ช่วยให้สามารถออกแบบโซลูชัน LiDAR ระดับยานยนต์ที่มีอัตราส่วนต้นทุนต่อประสิทธิภาพที่เหมาะสมที่สุดได้อย่างรวดเร็ว บริษัทเป็นผู้รับผิดชอบในการคิดค้นนวัตกรรมใหม่ ๆ ในแอปพลิเคชันตรวจจับยานยนต์และการเคลื่อนที่ระยะไกลที่ทันสมัย ด้วยเทคโนโลยีทั้งที่จดสิทธิบัตรแล้วหรือที่รอการอนุมัติมากกว่า 140 รายการ ที่ช่วยเสริมขีดความสามารถ ADAS และการขับขี่แบบอัตโนมัติ

ดูข้อมูลเพิ่มเติมเกี่ยวกับ LeddarTech ได้ที่ www.leddartech.com และบน LinkedIn, Twitter, Facebook และ YouTube.

ติดต่อ:Daniel Aitken รองประธานฝ่ายการตลาดโลก การสื่อสารและนักลงทุนสัมพันธ์ LeddarTech Inc.โทร.: + 1-418-653-9000 ต่อ 232 daniel.aitken@leddartech.com

ติดต่อนักลงทุนสัมพันธ์:InvestorRelations@leddartech.com
https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator และโลโก้ที่เกี่ยวข้องเป็นเครื่องหมายการค้าหรือเครื่องหมายการค้าจดทะเบียนของ LeddarTech Inc. และบริษัทในเครือ แบรนด์ ชื่อผลิตภัณฑ์ และเครื่องหมายอื่น ๆ ทั้งหมดเป็นหรืออาจเป็นเครื่องหมายการค้าหรือเครื่องหมายการค้าจดทะเบียนที่ใช้เพื่อระบุผลิตภัณฑ์หรือบริการของเจ้าของที่เกี่ยวข้อง

Avenue Bank Reimagines SME Business Banking with nCino

Australian new digital business bank redefines banking experience to enhance offerings for small and medium-sized businesses

SYDNEY, Australia, Sept. 26, 2022 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that Avenue Bank, an Australian start-up digital business bank specialising in serving small and medium-size businesses, is live on the nCino Bank Operating System®. Avenue Bank deployed nCino’s Commercial Banking Solution to support customer onboarding, origination, credit risk management and customer 360 view—providing their employees with key insights and the automation necessary to deliver a faster response and seamless experience for their customers.

“nCino embedded their high-quality solution into our greenfield digital strategy in just over 4 months. With their guidance, we’ve been able to design products and implement best-in-class technology to meet our needs—and the needs of our target customers,” said George Confos, CEO and Executive Director. “As a cloud-based, digital product-led business like nCino, our values and mission make this partnership a win-win for not just our customers, but for our people, too. nCino’s team was highly engaged throughout the entire project, making our team confident that Avenue Bank’s success was their top priority.”

Small and medium-sized enterprise (SME) businesses are a fundamental part of the global economy. nCino’s platform supports both the financial institution and the customer from the very beginning, to deliver an efficient, end-to-end banking relationship, enhancing customer relationships and increasing loan profitability and response time. nCino’s single platform helps drive Avenue Bank’s digital strategy that focuses on making timely, quality decisions and operating within a high-tech, low-touch environment.

“Across the industry, financial institutions can add significant value by adopting digital technologies like nCino to deliver faster customers insights, respond more quickly to new market trends, and scale efficiently to stay ahead of the competition,” said Mark Bernhardi, Managing Director of Australia and New Zealand at nCino. “It’s always an exciting opportunity to partner with another entrepreneurial and progressive organisation such as Avenue Bank and provide new and innovative ways to better serve their customers. Avenue is on a mission to exceed the business banking standards across the Australian market, and nCino’s platform is helping to fulfil that goal.”

About nCino
nCino (NASDAQ: NCNO) is the worldwide leader in cloud banking. The nCino Bank Operating System® empowers financial institutions with scalable technology to help them achieve revenue growth, greater efficiency, cost savings and regulatory compliance. In a digital-first world, nCino’s single cloud-based platform enhances the employee and client experience to enable financial institutions to more effectively onboard clients, make loans and manage the entire loan life cycle, and open deposit and other accounts across lines of business and channels. Transforming how financial institutions operate through innovation, reputation and speed, nCino is partnered with more than 1,750 financial institutions of all types and sizes on a global basis. For more information, visit www.ncino.com.

About Avenue Bank
Avenue Bank is a digital business bank, built for small to medium Australian businesses of the 21st century. Our mission is to put money in the hands of businesses. We’re intent on recreating the entire experience of what it means to be a business bank. Small businesses want banking solutions which meet their needs, which is why we’ve developed smarter, digitally-enabled products to free up cash, so Aussie businesses can do more with their money. Australian businesses are our sole focus and we’re determined to do things differently to help all our small business customers. Avenue Bank: Business banking done differently. To find out more visit www.avenuebank.com.au.

Media Contacts
North America
Ryan Kelly
+1 732.770.5942
ryan.kelly@ncino.com

APAC
Catalina Garcia, nCino
+61 418 215 423
catalina.garcia@ncino.com

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally include actions, events, results, strategies and expectations and are often identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans,” “seeks,” “estimates,” “projects,” “may,” “will,” “could,” “might,” or “continues” or similar expressions. Any forward-looking statements contained in this press release are based upon nCino’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent nCino’s expectations as of the date of this press release.  Subsequent events may cause these expectations to change and, except as may be required by law, nCino does not undertake any obligation to update or revise these forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially including, among others, risks and uncertainties relating to the market adoption of our solution and privacy and data security matters. Additional risks and uncertainties that could affect nCino’s business and financial results are included in reports filed by nCino with the U.S. Securities and Exchange Commission (available on our web site at www.ncino.com or the SEC’s web site at www.sec.gov). Further information on potential risks that could affect actual results will be included in other filings nCino makes with the SEC from time to time.

Cambridge Isotope Laboratories, Inc. (CIL) Partners With ISOtopic Solutions to Release the New Stable Isotope-Labeled and Unlabeled Crude Lipid Yeast Extracts

Cambridge Isotope Laboratories

Cambridge Isotope Laboratories

TEWKSBURY, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) — Cambridge Isotope Laboratories, Inc. (CIL) has partnered with ISOtopic Solutions to release the new stable isotope-labeled and unlabeled Crude Lipid Yeast Extracts. These are designed to render hundreds of fatty acids and lipids for use in MS lipidomics research and development.

Andrew Percy (Ph.D.), CIL’s MS ‘Omics Product Manager and Senior Applications Scientist for Mass Spectrometry, states: “These analytes are broadly dispersed across a multitude of metabolic classes and pathways. This represents the largest panel of stable isotope-labeled standards commercially available in a single mix for targeted profiling and relative quantification of the lipidome.”

Andrew goes on to say: “A major benefit of the stable isotope-labeled lipid yeast extract is that the fatty acids and lipids are uniformly 13C-labeled at high isotopic enrichment. 13C labeling provides superior isotopic stability and analytical reliability as compared to 2H (or deuterium) labeling.”

Gerrit Hermann (Ph.D.), founder and CEO of ISOtopic Solutions, states: “Up to now, the lack of suitable internal standards has been one of the major limiting factors to achieve absolute quantitation in the field of lipidomics. The use of internal standards is a prerequisite to ensure high precision and accuracy, as well as to correct for errors introduced during sample preparation procedures. However, due to the high number and structural diversity of lipid molecules, it is almost impossible to ensure molecule-specific stable isotope-labeled internal standardization. This explains why class-specific internal standards have been used to date. This U-13C-labeled lipid yeast extract might enable these shortcomings to be overcome. In fact, these U-13C-labeled yeast cell extracts have already been widely used in microbiological metabolism studies, including targeted quantitative metabolite profiling.”

Overall, these lipid yeast extract mixes (Cat nos. L-ISO1 and L-ISO1-UNL) are well suited for researchers performing MS lipidomics and integrative MS ‘Omics (involving lipidomics). Both of these products are available exclusively through CIL. To learn more about these new Crude Lipid Yeast Extracts, as well as the established Metabolite Yeast Extracts (Cat nos. ISO1 and ISO1-UNL), please visit isotope.com.

About Cambridge Isotope Laboratories, Inc.

CIL is the world’s largest manufacturer and global supplier of stable isotopes and stable isotope-labeled compounds used in research, environmental, neonatal, pharmaceutical, medical diagnostic, OLED, and industrial markets. CIL is an operating business owned by Otsuka Pharmaceuticals. The CIL business consists of two facilities in the Boston area of MA; a large isotope-enrichment production plant in Xenia, OH; CIL China; CIL Canada; ABX in Dresden, Germany; and Eurisotop in Saclay, France. For more information on CIL, visit isotope.com.

About Isotopic Solutions 

ISOtopic Solutions was founded as an analytical-biotechnological university spin-off from the University of Vienna. The ISOtopic Solutions product line consists of stable isotope-labeled biomolecules and labeled biomass for the standardization and validation of mass spectrometric analysis methods. As a clear mission statement, ISOtopic Solutions’ intention is to advance the scientific field by providing effective solutions to scientists and to people working in the field of analytical chemistry. For more information, visit isotopic-solutions.com.

Contact Information:
Crissy Krisko
crissyk@isotope.com
1.978.749.8000

Related Images

Image 1: Cambridge Isotope Laboratories

Cambridge Isotope Laboratories

Image 2: ISOtopic Solutions

ISOtopic Solutions

This content was issued through the press release distribution service at Newswire.com.

Attachment

Azerbaijani currency rates for September 27

BAKU, Azerbaijan, September 27. The official exchange rate of the US dollar and euro against Azerbaijani manat as of September 27, 2022 is set at 1.7 and 1.6384 manat, respectively, Trend reports via the Central Bank of Azerbaijan (CBA).

According to CBA, the manat rate to other currencies on September 27 is as follows:

CurrenciesOfficial exchange rate
1 US dollarUSD1.7
1 EuroEUR1.6384
1 Australian dollarAUD1.1025
1 Argentine pesoARS0.0116
1 Belarus rubleBYN0.6735
1 Brazil realBRL0.3153
1 UAE dirhamAED0.4628
1 South African randZAR0.0944
100 South Korean wonKRW0.1191
1 Czech korunaCZK0.0665
1 Chilean pesoCLP0.1714
1 Chinese yuanCNY0.2373
1 Danish kroneDKK0.2203
1 Georgian lariGEL0.5989
1 Hong Kong dollarHKD0.2166
1 Indian rupeeINR0.0209
1 British poundGBP1.8311
100 Indonesian rupiahIDR0.0112
100 Iranian rialsIRR0.004
1 Swedish kronaSEK0.1505
1 Swiss francCHF1.7144
1 Israeli shekelILS0.4834
1 Canadian dollarCAD1.2417
1 Kuwaiti dinarKWD5.4713
1 Kazakh tengeKZT0.0036
1 Kyrgyz somKGS0.0208
100 Lebanese poundLBP0.1126
1 Malaysian ringgitMYR0.3687
1 Mexican pesoMXN0.0836
1 Moldovan leuMDL0.0873
1 Egyptian poundEGP0.0872
1 Norwegian kroneNOK0.158
100 Uzbek soumUZS0.0154
1 Polish zlotyPLN0.3447
1 Russian rubleRUB0.0289
1 Singapore dollarSGD1.1841
1 Saudi riyalSAR0.4521
1 SDR (Special Drawing Rights of IMF)XDR2.1624
1 Turkish liraTRY0.0921
1 Taiwan dollarTWD0.0535
1 Tajik somoniTJS0.1675
1 New Turkmen manatTMT0.4857
1 Ukrainian hryvnaUAH0.0462
100 Japanese yenJPY1.1762
1 New Zealand dollarNZD0.966

Source: TREND News Agency

Singapore-Helsinki flight makes emergency landing in Baku

BAKU, Azerbaijan, September 27. The captain of the Singapore-Helsinki flight of Finnair Airlines sent an emergency landing request to Heydar Aliyev International Airport due to a sudden deterioration in the passenger’s health, Trend reports via press service of Heydar Aliyeva International Airport.

The Airbus A350 plane landed at Baku airport at 02:31 local time.

The passenger was provided with medical assistance and it was decided to place him in one of the medical clinics in Baku. The plane took off from Baku to Helsinki at 05:50.

Source: TREND News Agency

As Ebola Spreads, Ugandan Medical Interns Strike Over Safety

As Uganda reports more deaths from the latest Ebola outbreak in the country, medical interns at the hospital handling most of the cases have gone on strike. The interns say they are not being provided with adequate personal protective equipment against the deadly virus, which causes a hemorrhagic fever. Uganda’s health ministry has so far confirmed five deaths and 18 probable fatalities out of 36 cases.

Ugandan Health officials say they are holding talks with striking interns at central Mubende district’s hospital, which is handling most of the country’s spreading Ebola outbreak.

President for the Federation for Uganda Medical Interns, Dr. Musa Lumumba, says there is not enough personal protective gear for the interns at the hospital.

Speaking to VOA by phone, he called on Uganda’s Ministry of Health to urgently address the issue to protect doctors-in-training.

“The issue of not having accommodation, so they stay in communities, which communities have got cases of Ebola,” Lumumba said. Protection of those at the frontline. And those at the frontline are the health care workers.”

Uganda Medical Association President, Dr. Samuel Oledo, told VOA one intern, three staff, and a medical student have been confirmed for exposure to the virus and at least three senior health officers (SHO) are showing symptoms.

“We have 34 interns in Mubende. And we have less than 12 doctors employed on the ground,” Oledo said. “If you have interns and they are pulling out at once, it’s catastrophic. And the justifications are clear, honestly. Results have come out today and one of the SHOs who actually performed surgeries with one of the interns on one case has become positive of Ebola.”

Oledo said they suspect as many as 104 medical students in Mubende hospital have been exposed to the virus.

Uganda’s Ministry of Health has yet to confirm the exposures and infections of students and staff at the hospital.

Ministry spokesman Emmanuel Ainebyoona denied there is a lack of protective equipment there to guard against Ebola.

“All the protective gear to safeguard their life is available,” Ainebyoona said. “But like [with] any other infectious disease, fear will be expected. But we are working to ensure that we engage and counsel. And ensure that there are teams to respond.”

Despite the spreading virus, Uganda’s Health Ministry said the situation is under control but acknowledged that three people suspected of being infected with the virus fled Mubende’s isolation unit on Monday.

Officials say security has been beefed up since to avoid a repeat.

Uganda’s Ebola outbreak was first detected last week in Mubende, a central district, but has since spread to neighboring districts Kyegegwa and Kasanda.

Some schools in Kyegegwa have shut down for two weeks to protect students.

First reports of a possible Ebola outbreak came from Kyegegwa’s Kyaka 11 refugee camp, raising alarm bells of a possible quick spread in the packed camp.

But testing ruled out an outbreak in the camp.

After Mubende’s cases were confirmed, the U.N.’s Refugee Agency UNHCR said it added controlled entry measures at refugee settlements.

“We are stepping up some assistance programs that had been curtailed due to lack of funding since July,” said Matthew Crentsil, the UNHCR Uganda representative. “That is procurement of soap. You would agree with me, this is fundamental in curbing the spread of Ebola.”

Uganda has yet to identify the source of the Ebola outbreak, which is the Sudan strain of the virus.

The Sudan strain is less common than the Zaire strain and has no current, effective vaccine.

Uganda’s last Ebola outbreak in 2019 was the Zaire strain. It last reported a Sudan strain outbreak in 2012.

Source: Voice Of America